AdvisorShares Pure US Cannabis ETF Fundamental Analysis (AMEX: MSOS)
AdvisorShares Pure US Cannabis ETF Fundamental Analysis (AMEX: MSOS)
AdvisorShares Pure US Cannabis ETF (AMEX: MSOS) shows weak financial fundamentals with a PE ratio of 13.69, profit margin of 0.00%, and ROE of 0.00%. The company generates N/A in annual revenue with N/A year-over-year growth of N/A.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 25.0/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze MSOS's fundamental strength across five key dimensions:
Efficiency Score
WeakMSOS struggles to generate sufficient returns from assets.
Valuation Score
ModerateMSOS shows balanced valuation metrics.
Growth Score
ModerateMSOS shows steady but slowing expansion.
Financial Health Score
ModerateMSOS shows balanced financial health with some risks.
Profitability Score
WeakMSOS struggles to sustain strong margins.
Key Financial Metrics
Is MSOS Expensive or Cheap?
P/E Ratio
MSOS trades at 13.69 times earnings. This suggests potential undervaluation.
Debt/Equity
AdvisorShares Pure US Cannabis ETF has a debt-to-equity ratio of 0.00, indicating its leverage.
How Well Does MSOS Make Money?
Net Profit Margin
For every $100 in sales, AdvisorShares Pure US Cannabis ETF keeps $0.00 as profit after all expenses.
Operating Margin
Core operations generate 0.00 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $0.00 in profit for every $100 of shareholder equity.
ROA
AdvisorShares Pure US Cannabis ETF generates $0.00 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
FCF Per Share
Each share generates $0.00 in free cash annually.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
N/A
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
N/A
vs 25 benchmark
P/B Ratio
Price to book value ratio
N/A
vs 25 benchmark
P/S Ratio
Price to sales ratio
N/A
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.00
vs 25 benchmark
Current Ratio
Current assets to current liabilities
0.00
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.00
vs 25 benchmark
ROA
Return on assets percentage
0.00
vs 25 benchmark
ROCE
Return on capital employed
0.00
vs 25 benchmark
How MSOS Stacks Against Its Sector Peers
| Metric | MSOS Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | N/A | 20.65 | N/A |
| ROE | 0.00% | 646.00% | Weak |
| Net Margin | 0.00% | -1501.00% (disorted) | Weak |
| Debt/Equity | 0.00 | 0.88 | Strong (Low Leverage) |
| Current Ratio | 0.00 | 829.12 | Weak Liquidity |
| ROA | 0.00% | -568.00% (disorted) | Weak |
MSOS outperforms its industry in 1 out of 5 key metrics, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews AdvisorShares Pure US Cannabis ETF's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
N/A
Industry Style: Value, Dividend, Cyclical
EPS CAGR
N/A
Industry Style: Value, Dividend, Cyclical
FCF CAGR
N/A
Industry Style: Value, Dividend, Cyclical